Hi {{first name | there}},

Blood pressure has terrible branding.

It comes in two numbers, requires a cuff that squeezes your arm uncomfortably at exactly the moment you are supposed to be relaxed, and is usually delivered with the emotional energy of a car-inspection report.

Meanwhile, the longevity internet will spend forty-five minutes on glucose curves, HRV, REM density, creatine timing, peptides, methylation clocks, Zone 2, and whether beet powder belongs in a pre-workout stack.

This is backwards.

In the GBD 2019 risk-factor analysis, high systolic blood pressure was the leading Level 2 risk factor for attributable deaths globally. It was tied to 10.8 million deaths, about 19% of all deaths that year.

So yes: blood pressure matters for longevity. A lot.

But the more interesting point is not just “lower is better.”

Blood pressure is a living signal. It changes with waking, sleep, caffeine, alcohol, salt, exercise, pain, anxiety, apnea, medications, hormones, hydration, and whether your arm was dangling sadly off the exam table.

Most people can tell you one blood pressure reading.

Almost nobody can tell you their blood pressure pattern.

That is the upgrade we should care about.

We did this with glucose via CGM. We did this with HR via HRV. Blood pressure deserves the same move from static score to dynamic physiology.

Today we are going there:

The old question is: what is your blood pressure?

The better question is: what does your blood pressure do?

I want to know:

Blood pressure data can be wrong for painfully ordinary reasons: wrong cuff size, crossed legs, unsupported arm, no rest period, talking, recent caffeine or exercise, nicotine, pain, anxiety, decongestants, NSAIDs, arrhythmia, or an unvalidated device.

Bad blood pressure data creates false precision.

Bad frequent data creates false precision at scale.

That is how you get a beautiful graph of garbage.

(Or in other words, “trash in, trash out.”)

This is why I like the BPV frame. It breaks the signal into pieces:

The HRV comparison is useful, but only to a point.

With HRV, higher often suggests more autonomic flexibility. Your heart rate should vary beat to beat because the nervous system is constantly adjusting.

With BPV, the story is different. A healthy vascular system should buffer pressure. It should not let BP whip around like a toddler with espresso unless the context really demands it.

The bridge is baroreflex and autonomic control.

Simplified: higher HRV can suggest flexibility which is good. Lower BPV can suggest the control system is doing its job.

Mean BP is still the main pressure load. If your home average is high, the first problem is not that the graph is aesthetically volatile. The first problem is high pressure exposure.

This is the official map:

This is one place where the usual medical threshold and the longevity threshold do not feel identical.

A PCP may reasonably say “let’s watch it” when someone is young, low-risk, and hovering in the elevated range. But from a longevity point of view, the goal is not to barely dodge a diagnosis. The goal is to reduce decades of unnecessary pressure exposure without overshooting into dizziness, falls, poor perfusion, or side effects.

Translation: if your average is consistently above the normal range, especially in the 130s/80s or higher, this is a problem that compounds.

Elevated pressure over years remodels arteries, thickens the heart, injures kidney microvasculature, strains the retina, and shifts cerebral autoregulation. The body can adapt to higher pressure, but adaptation is not protection. It is remodeling.

BPV turns “my BP spiked” into a better question:

When the measurement is clean, what pattern keeps repeating?

A healthy vascular system should absorb ordinary stressors and return to baseline. A more vulnerable system may overshoot, stay high, fail to dip at night, surge in the morning, or swing because sleep, alcohol, pain, stimulants, medication timing, apnea, kidney-volume biology, arrhythmia, autonomic dysfunction, or bad measurement is pulling the signal around.

Spikes are usually a clue, not the whole diagnosis.

And no, the message is not “spikes cause strokes, go panic.” In acute stroke and brain hemorrhage settings, higher BP variability is consistently associated with worse outcomes. That supports the dynamic-physiology frame. It does not mean scary neurologic symptoms should be self-managed at home.

Stroke symptoms are emergency symptoms.

Now for the part of this topic that gets people weirdly excited.

Beets. Cialis. Minoxidil. Nitric oxide. Blood flow. Pumps. Hair. Erections. Smooth muscle. This is the part of vascular biology that escaped the textbook and started wearing a podcast microphone.

I am not mad about it. It is interesting.

But it needs to be approached with caution.

BP is not just “fluid in a hose.” It is vascular tone, endothelial signaling, autonomic control, kidney-volume regulation, arterial stiffness, and pharmacology all talking at once.

Nitric oxide is one of the major “relax the vessel” signals. Endothelial cells make NO; NO helps vascular smooth muscle relax through the cGMP pathway; impaired NO bioavailability is part of the endothelial dysfunction story in hypertension and vascular aging. This review on nitric oxide in hypertension is old, but still useful for the basic map.

That is why “boost NO” became such an internet phrase.

Here is the cleaner version:

Beets and nitrate-rich plants are the sane food version. Dietary nitrate from beets, arugula, spinach, and similar plants can feed the nitrate-nitrite-NO pathway. A 2013 meta-analysis found inorganic nitrate and beetroot juice lowered systolic BP by about 4.4 mmHg in small randomized trials. A newer 2024 hypertension-focused meta-analysis found about a 5.3 mmHg clinic systolic BP reduction, although certainty was low and the 24-hour BP signal was not significant.

My take: eat the arugula. Drink beet juice if you like beet juice. Do not fire your clinician because your smoothie is aggressively magenta.

Tadalafil is interesting for a different reason. Yes, Cialis. It is FDA-approved for erectile dysfunction and BPH, and used at different dosing for pulmonary arterial hypertension. PDE5 inhibitors touch the NO-cGMP pathway and can modestly lower systemic BP, which makes the vascular biology genuinely relevant. A 2024 meta-analysis of cohort studies found PDE5 inhibitor use was associated with lower cardiovascular events and mortality, and a tadalafil ambulatory-BP trial showed modest BP lowering in hypertensive subjects.

My take: this is interesting enough to discuss seriously. It is not proof that tadalafil is a general longevity drug, although some clinics will prescribe a low dose for this purpose (yes, even to women).

The PDE5/longevity signals are mostly observational, mostly in men using these drugs for ED/BPH, and vulnerable to healthy-user bias, prescribing selection, and baseline vascular-health confounding. Tadalafil may be a reasonable comorbidity-aligned prescription in the right person. It is not a first-line mild-hypertension drug.

It is also prescription medicine, not casual longevity candy. It is contraindicated with nitrates and riociguat because the combination can cause dangerous hypotension. That includes nitroglycerin, isosorbide, and recreational poppers or amyl nitrite. It also needs caution with alpha-blockers, low baseline BP, orthostasis, and complex cardiovascular disease.

Minoxidil has the strangest public-relations arc of the three. Many people now know it from Rogaine or low-dose oral minoxidil for hair. But minoxidil is also a potent direct vasodilator originally used for resistant or severe hypertension. It intersects with KATP-channel biology, a real vascular-tone and cardiac stress-response pathway; in cardiac myocyte/tissue models, minoxidil opened mitochondrial KATP channels and showed cardioprotective effects.

My take: minoxidil is not “just hair.” It can definitely lower your BP, to the point where I’d caution folks taking it for other purposes to watch out if you’re feeling lightheaded.

While it’s tempting to jump to conclusions, I do not know of convincing human evidence that minoxidil slows vascular aging, improves healthspan, or extends lifespan. Oral minoxidil can cause fluid retention, tachycardia, edema, lightheadedness, and orthostatic symptoms. The DailyMed label also warns about pericardial effusion, which is why “low dose” does not mean “casual” or OTC.

If someone is taking it, I want BP, pulse, edema history, weight changes, symptoms, dose, and medication history in the same room.

BPV literature has the classic medical personality: useful, promising, complicated, and not yet packaged into a clean consumer score.

A Nature Reviews Cardiology review and a newer Journal of Hypertension review split BPV into several buckets: visit-to-visit BPV, day-to-day home BPV, 24-hour ambulatory BPV, nighttime dipping, morning surge, and beat-to-beat BPV.

That is why BPV is not yet a tidy number you should chase in an app.

But the signal is strong enough to pay attention:

So does BPV have a normal range?

Not really.

BPV is more mature as a risk signal and clinical clue than as an independent treatment target. We do not yet have clean proof that chasing BPV down, separate from lowering mean BP and fixing drivers of lability, improves outcomes.

So I would not tell people to chase a BPV score.

I would tell them to build a clean seven-day BP log and look for repeatable patterns.

My hope is that one day soon, we’ll have a wearable that can look algorithmically at BP patterns over populations to inform us what is more or less healthy.

Here is the practical version available today, if you just get a regular BP cuff and record your BP measurements over time (best would be if you measured several times each day during a normal week - scroll to end to see best tips).

1. The average pressure load. A single 148/90 after a terrible night, two espressos, and a decongestant is not the same as a week of clean home readings averaging in the 130s/80s. The second one deserves a clinician conversation. Repeated 140s/90s deserve even more urgency. Stable high BP is still high BP.

2. Morning versus evening. Are mornings consistently higher than evenings? That can point toward sleep apnea, alcohol, late sodium, poor sleep, overnight sympathetic tone, or medication wearing off before morning. Morning BP is often a clue about what happened overnight.

3. Scatter under similar conditions. If readings are all over the place under supposedly similar conditions, I first ask whether the data are real. Wrong cuff size, unsupported arm, talking, crossed legs, recent caffeine, pain, panic, arrhythmia, or a wrist device held in the wrong position can manufacture variability. If technique is clean and scatter persists, then the biology gets more interesting.

4. Trigger patterns. Tag the obvious culprits: poor sleep, alcohol, pain, travel, stimulants, decongestants, NSAIDs, missed medication, salty meals, illness, panic, late exercise, menstrual-cycle or perimenopause symptoms, oral minoxidil, and caffeine timing.

You are not trying to create a perfect quantified-self diary. You are trying to avoid pretending a Friday-night margarita BP and a rested Tuesday-morning BP are the same experiment.

5. Symptoms. Lightheadedness, faintness, palpitations, chest symptoms, shortness of breath, swelling, severe headache, neurologic symptoms, or very low readings change the interpretation. A BP log without symptoms can mislead you. Symptoms without BP and pulse context can mislead you too.

6. Nighttime clues. A home cuff cannot really show whether you dip normally during sleep. But high morning readings, resistant hypertension, sleep-apnea symptoms, kidney disease, diabetes, or a mismatch between clinic and home readings are reasons to consider ambulatory blood pressure monitoring. ABPM is annoying. It is also still the best way to see nighttime BP, non-dipping, morning surge, masked hypertension, and white-coat effect.

The goal is to separate four different situations:

Okay, so how do you take a pristine BP measurement?

1. Use a validated upper-arm cuff. Not every cuff from a good brand is validated. Exact model matters. ValidateBP and STRIDE BP are useful starting points.

2. Measure with good (relaxed and supported) posture. Back supported. Feet flat. Arm supported at heart level. Rest quietly for about five minutes. Do not talk. Avoid caffeine, nicotine, exercise, and acute stressors for about 30 minutes when possible.

3. Run a short protocol, not random drive-by readings. For one week, take two readings in the morning and two in the evening, ideally at consistent times and before caffeine/exercise. Keep all the readings. Do not delete the annoying ones unless there was a clear technical error.

4. Average before you panic. The point is not to react to the highest number. The point is to ask what the average and repeated pattern show. A scattered log with no context is noise with decimals.

5. Track context lightly. Sleep, alcohol, caffeine, exercise, pain, illness, travel, NSAID/decongestant/stimulant use, missed meds, salty meal, panic, cycle/perimenopause symptoms, oral minoxidil, unusual stress. Short tags are enough.

Caffeine is a good example. It is not inherently bad. But it can create fake confusion in a BP log. A 2023 dose-response meta-analysis found that caffeine supplementation modestly increased systolic and diastolic BP, especially at higher doses. The practical question is not “is coffee good or bad?” It is: what happens to your BP after your specific dose, timing, sleep debt, and stimulant stack?

If BP is a question and caffeine is already part of your life, run the boring experiment: measure before caffeine and again 60 to 90 minutes after, on several similar mornings, with the same cuff and technique.

6. Interpret in the right order. First, confirm the measurements are clean. Second, look at average BP. Third, look at pattern: morning versus evening, tight cluster versus scatter, repeated highs under clean conditions, symptoms, and context tags.

7. Treat mean BP first. If the home or ambulatory average is high, the main intervention is still guideline-based BP control. Stable hypertension is still hypertension.

8. Lower the drivers, not just the score. Sleep, apnea, alcohol, pain, stimulants, sodium and potassium pattern, exercise, medication adherence, long-acting regimens, orthostasis, arrhythmia, and measurement technique often matter more than the BPV number itself.

On the intervention side, I would not first jump to a supplement. If lifestyle (fixing sleep, moving more) isn’t working out, then turn to boring pharmacology: take medication consistently, avoid short-acting peaks and troughs when possible, and use long-acting regimens that control the full 24-hour pattern. Some evidence suggests calcium-channel blockers and thiazide-type diuretics reduce variability more than beta blockers in hypertension populations, but that is not a DIY medication-switching rule. Comorbidities still matter. This warrants working with an experienced clinician.

You may have seen headlines about Apple Watch and blood pressure.

In September 2025, Apple announced hypertension notifications for newer Apple Watch models. The FDA 510(k) summary describes a feature that uses the optical heart sensor and machine learning to look for patterns suggestive of chronic high BP over 30-day windows.

Importantly, it does not measure BP directly. It does not show systolic and diastolic values. It is not meant to diagnose hypertension, monitor treatment response, or replace a cuff. Apple’s validation paper says notified users should confirm with a standard cuff and clinician follow-up.

FDA summary sensitivity was 41.2% and specificity was 92.3%. Plain English: the feature is designed to avoid too many false alarms, not to catch every case.

Do not panic over one high reading if you feel well and the reading was taken under messy conditions. Repeat it correctly.

If a reading is around 180/120 or higher, repeat after sitting quietly for five minutes. If it stays there, contact urgent medical care or your clinician the same day. If there are neurologic symptoms, chest pain, shortness of breath, confusion, severe headache, fainting, pregnancy, severe back pain, numbness or weakness, vision change, or trouble speaking, that is emergency territory, not a spreadsheet moment. The American Heart Association has a simple home-BP sheet with this escalation frame.

Do not decide that a wearable notification means you have hypertension. Use it as a prompt to confirm with a validated cuff.

Do not use cuffless or watch-based readings to adjust medication unless your clinician has explicitly built that into your plan.

Do not mix tadalafil with nitrates or NO-donor drugs, including nitroglycerin, isosorbide, or recreational poppers/amyl nitrite. Also avoid it with riociguat. That is not a longevity experiment. That is a dangerous-hypotension problem.

Do not treat beetroot juice as a substitute for diagnosing or treating hypertension. It is food with interesting vascular biology, not a medical plan.

Do not ignore oral minoxidil in the BP story just because the prescription says “hair.” Dose, pulse, edema, weight gain, lightheadedness, orthostatic symptoms, shortness of breath, chest symptoms, and comorbidities matter.

Do not assume bedtime dosing is universally better. Some studies show evening dosing can reduce morning surge, but the large TIME trial did not find a major cardiovascular outcome advantage for routine evening dosing. Timing should be individualized around control, adherence, side effects, nocturia, orthostasis, and measured patterns.

Do not turn non-dipping, morning surge, or a high BPV metric into a self-treatment project. Use those patterns to ask better questions: Do I need ABPM (An Ambulatory Blood Pressure Monitor - essentially a not very high-tech continuous BP monitor)? Is sleep apnea in play? Is the regimen wearing off? Are readings being taken correctly? Is my average BP actually controlled?

BPV is not a replacement for the basics: average BP, ApoB, smoking, diabetes, kidney health, sleep apnea, exercise capacity, body composition, alcohol, and medication adherence.

It is a way to stop missing the part of the basics that happens between clinic visits.

It needs better respect.

One clean cuff, used well, can tell you whether your vascular system is calm, over-pressurized, under-recovered, or being trolled by bad technique.

That is not more frantic.

That is more useful.

The goal is not to turn your wrist into another anxiety machine.

The goal is to stop mistaking one clinic reading for a healthy system.

Stay sharp,

Hillary Lin, MD

For a deeper cardiovascular-risk companion, check out why standard testing can miss risk that is already building underneath the surface.

The Heart Attack You Won't See Coming (Even With 'Good' Stats).

Watch on YouTube | Subscribe to The Longevity Show

💉 GLP-1s keep escaping the weight-loss box: Weekly semaglutide reduced heavy drinking days in people with alcohol use disorder and obesity receiving CBT, and the PCOS-to-PMOS naming shift points to the same broader truth: GLP-1s sit at the intersection of metabolism, reward, and reproductive endocrinology, not just appetite.

😴 Sleep and light are system signals: A Nature paper mapped sleep patterns against biological-aging clocks while objective daytime light exposure predicted lower GI cancer incidence and mortality, which keeps circadian context squarely inside prevention even when the evidence is observational.

👁️ AI screening only matters if the loop closes: A meta-analysis found AI diabetic-retinopathy screening can be more sensitive than store-and-forward screening, but image quality, false positives, follow-up capacity, and ownership of the next step still determine whether anyone gets better care.

🦴 Fracture risk is not just a DEXA number: In older adults, gait speed, grip strength, depressive symptoms, and their combinations tracked fracture risk, which is why longevity care has to include function, mood, medications, vision, falls, and bone.

🫀 AF ablation success starts before the EP lab: A 152-study meta-analysis linked recurrence after ablation with sleep apnea, smoking, metabolic syndrome, hypertension, alcohol, obesity, diabetes, kidney disease, and periodontitis, because rhythm problems rarely live apart from the vascular and metabolic environment.

🧩 Precision medicine still has to become follow-through: The PRISM young-onset diabetes RCT improved multi-target attainment and distress but not 3-year complications, which is the whole problem with precision medicine in one sentence: stratification is not the product; the care loop is.

The Aging Code Summit, May 26-27, Cambridge, MA. I am speaking Wednesday, May 27, at Longevity Global Boston's summit on moving aging science from discovery into interventions.

NYC Tech Week: "Sick Care is Dead. What Comes Next?", June 2, New York, NY. A brunch panel on the consumer health stack: GLP-1s by text, gyms as longevity clinics, AI triage, and what gets lost or gained when health moves outside traditional institutions.

NYC AI x Longevity Summit, June 4-5, Long Island City, Queens. I am on the AI in Clinical Practice panel on June 4 with Longevity Global.

Dry Eye Society of the Americas Conference, July 10-11, New York, NY. A clinician-focused dry eye and ocular surface meeting.

Science of Skin Summit, September 17-20, Austin, TX. Speaking on AI in dermatology and skin and hair as windows into biological age.

Livelong Women's Health Summit NYC, September 25-26, New York, NY. A two-day summit on women's health, longevity, and agency. My role is still being finalized, but it is on the fall calendar.

A few reader-supported partners that fit the longevity stack:

If you want physician-guided biological age testing, start on the testing page. It includes epigenetic age testing with consultation, plus organ-specific proteomic and SystemAge assessments when they fit the clinical question.

Have a question or topic you want covered? Reply to this email.

Was this forwarded to you? Subscribe here to get The Longevity Letter in your inbox.